Heel R C, Brogden R N, Pakes G E, Speight T M, Avery G S
Drugs. 1980 Apr;19(4):249-67. doi: 10.2165/00003495-198019040-00001.
Nefopam is a non-narcotic analgesic not structurally related to other analgesic drugs. It is effective by the oral and parenteral routes, and when appropriate dose ratios were compared in short term studies it was shown to produce analgesia comparable to that with the oral analgesics aspirin, dextropropoxyphene and pentazocine, as well as that with 'moderate' doses of parenteral morphine, pethidine and pentazocine. However, when 'higher' dose ratios were compared, morphine and pethidine were usually more effective than nefopam, possibly due to a 'ceiling effect' for analgesia which may occur with higher doses of nefopam, as with other simple analgesics. Although a few patients with chronic pain have received nefopam for several weeks, further studies are needed to clarify its continued effectiveness and safety when used over long periods. In most patients nefopam has been relatively well tolerated, the most frequent side effects being sweating, nausea and in some studies sedation.
奈福泮是一种非麻醉性镇痛药,在结构上与其他镇痛药无关。它通过口服和肠胃外途径有效,在短期研究中比较适当剂量比时,发现它产生的镇痛效果与口服镇痛药阿司匹林、右丙氧芬和喷他佐辛相当,也与“中等”剂量的肠胃外吗啡、哌替啶和喷他佐辛相当。然而,当比较“较高”剂量比时,吗啡和哌替啶通常比奈福泮更有效,这可能是由于奈福泮高剂量时可能出现镇痛的“天花板效应”,其他简单镇痛药也有此现象。虽然少数慢性疼痛患者接受奈福泮治疗数周,但需要进一步研究以阐明长期使用时其持续有效性和安全性。在大多数患者中,奈福泮耐受性相对良好,最常见的副作用是出汗、恶心,在一些研究中还有镇静作用。